Cocer Peptides ye ŋlɔe 
ŋkeke 24 enye sia.
Lãmetsiŋusẽ ƒe dɔwɔwɔ kple lãmenugbagbeviwo ƒe dɔwɔwɔ ɖɔa amegbetɔ ƒe ŋutilã ƒe asitɔtrɔ, ŋusẽ ƒe dadasɔ, kple tsitsi kple tsitsi to lãmetsiŋusẽ ƒe kadodo deŋgɔ aɖe dzi. Homeostasis sia ƒe tɔtɔ ate ŋu ahe lãmesẽnya veviwo abe lãmenugbagbeviwo ƒe dɔwɔwɔ, lolo akpa, kple tsitsi ƒe kuxiwo vɛ. Agbenɔnɔ ƒe nusiwo dometɔ aɖewoe nye nuɖuɖu gbegblẽ (le kpɔɖeŋu me, nuɖuɖu siwo me nuɖuɖu siwo ŋu wotrɔ asi le sɔ gbɔ ɖo, carbohydrates siwo ŋu wokɔ, kple nusiwo wotsɔ kpe ɖe eŋu), anyinɔƒe nɔnɔ, alɔ̃madɔmadɔ nyuie, kple nuteɖeamedzi nye nu vevi siwo hea lãmenugbagbeviwo ƒe dɔmawɔmawɔ nyuie vɛ. Menye ɖeko nu siawo kpena ɖe lolo akpa ŋu tẽ ko o, ke wotrɔa lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dzesiwo hã eye wonaa ŋutilã ƒe dɔdzẽ toa oxygen ƒomevi siwo wɔa dɔ (ROS) siwo exposome factors hena vɛ dzi, si gagblẽa nu le lãmenugbagbeviwo ƒe dɔwɔwɔ kple lãmenugbagbeviwo ƒe lãmesẽ ŋu ɖe edzi. Le kpɔɖeŋu me, dɔgbo me nugbagbevi suesuewo ƒe dɔmawɔmawɔ nyuie kple lãmetsiŋusẽ ƒe dɔléle siwo nuɖuɖu hena vɛ—siwo dometɔ aɖewoe nye insulin ƒe dɔlélenutsiŋutete kple lãmetsiŋusẽ bubu siwo kpɔa gome le lãmenugbagbeviwo ƒe dɔwɔwɔ kple nuɖuɖu ƒe nuwɔna me ƒe tɔtɔ—nye mɔnu siawo siwo gblẽa nu le ame ŋu.
Le nɔnɔme sia ta la, nudede lãmetsiŋusẽ ƒe dodo kple nuwo ƒe asitɔtrɔ ƒe dɔwɔwɔwo me pɛpɛpɛ le vevie ŋutɔ na lãmesẽ me léle ɖe asi le ɖoɖowɔɖi ƒe mɔ veviwo katã dzi, abe lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ, lolo dzi ɖuɖu, tsitsi ƒe lãmetsiwo ƒe ɖoɖowɔwɔ, kple ŋusẽ ƒe asitɔtrɔ ƒe nyonyome ene. Atike siwo wotu ɖe peptide dzi, siwo ƒe dzesi enye nugbagbewo ƒe dɔwɔwɔ gã kple taɖodzinu tɔxɛ sesẽ la, ɖea viɖe tɔxɛwo fiana le mɔ vevi siawo me, eye wonaa egbɔkpɔnu yeyewo hena mɔxexe ɖe dɔléle siwo do ƒome kplii nu kple wo dada.
Lãmetsiŋusẽ ƒe Lãmesẽ Kple Lãmetsiŋusẽ ƒe Dɔwɔwɔ
Lãmetsiŋusẽ ƒe kadodo sesẽ aɖee nye lãmenugbagbevi siwo wɔa lãmetsi siwo do ƒome kple ŋusẽ wɔwɔ, wo zazã, wo dzadzraɖo, kple nuɖuɖu nana ƒe nuwɔna eye woɖea wo ɖe go. Dzesimɔ nyuiwo le vevie na lãmenugbagbeviwo ƒe dɔwɔwɔ nyuie. Lãmetsiŋusẽ ƒe lãmesẽ kple lãmenugbagbeviwo ƒe dɔwɔwɔ me léle ɖe asi le vevie ŋutɔ, eye peptide-nuwɔnawo ƒe dɔwɔwɔ ƒe akpa veviwoe nye esiawo:
1. Metabolism Management: Glycemic Homeostasis Gbugbɔgaɖoanyi Kple Takpɔkpɔ Tso Kuxiwo Me
Le lãmenugbagbeviwo ƒe dɔwɔwɔ ƒomevi 2 dzikpɔkpɔ bliboe me la, atike siwo wotu ɖe peptide dzi nyea dɔwɔnu veviwo hena suklidɔ dzi ɖuɖu to insulin ƒe dodo kple eŋudɔwɔwɔ nyuie wu me.
Insulin ƒe dɔwɔwɔ nyuie dodo ɖe ŋgɔ
Peptide aɖewo (le kpɔɖeŋu me, GLP-1 receptor agonists semaglutide, mazdutide) doa dɔgboa ƒe β-lãmenugbagbeviwo ƒe sukli ƒe seselelãme ɖe ŋgɔ, si doa insulin ƒe dodo si didi ɖe ŋgɔ esime wòxea mɔ na sukli ƒe dodo eye wòɖea aklã me sukli ƒe dodo dzi kpɔtɔna. Esia nana sukli si le ʋu me ƒe agbɔsɔsɔ le nutsitsidɔ kple nuɖuɖu megbe nyona ɖe edzi ŋutɔ.
Lãmetsiŋusẽ ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ: plasma sukli ƒe ɖoɖowɔwɔ (2023). Tso ScienceDirect me.
Dɔgbo ƒe β-lãmenugbagbeviwo ƒe dɔwɔwɔ ta kpɔkpɔ
To β-lãmenugbagbeviwo ƒe tsɔtsrɔ̃ ɖe megbe eye wodo woƒe dzidziɖedzi ɖe ŋgɔ me la, atike siwo wotu ɖe peptide dzi nana lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe ŋgɔyiyi nɔa blewu. Le dɔnɔ aɖewo gome la, esia nana sukli si le lãmenugbagbeviwo me ƒe ɖoɖowɔwɔ nyona ɖe edzi eye wòɖea ŋuɖoɖo ɖe insulin si le gota ŋu dzi kpɔtɔna.
Mɔxexe ɖe kuxiwo nu
Suklidɔ dzi ɖuɖu atraɖii eye wòli ke ɖea ʋuka suewo ƒe kuxiwo abe suklidɔ ƒe ayikudɔ kple ŋku ƒe dɔléle ene ƒe afɔkua dzi kpɔtɔna. Enaa ʋukawo ƒe dɔwɔwɔ nyuie hã nyona ɖe edzi, eɖea dzitodzito me nudzɔdzɔwo ƒe dzɔdzɔ dzi kpɔtɔna, eye wònaa agbenɔnɔ ƒe nyonyome nyona ɖe edzi.
2. Kpekpeme Dzi kpɔkpɔ: Multidimensional Sedede na Ŋutilã ƒe Nɔnɔme Nyuitɔ
Le ame siwo lolo akpa kple esiwo lolo akpa gome la, atike siwo wotu ɖe peptide dzi ɖoa dadasɔ yeye aɖe ɖe ŋusẽzazã kple gazazã dome to titina kple gota gome nuwɔna eve dzi.
Nuɖuɖudzroame ƒe nutete le titina
Satiety peptides (le kpɔɖeŋu me, GLP-1 receptor agonists) wɔa dɔ le hypothalamic nuɖuɖudzraƒea, xea mɔ na dɔwuame ƒe dzesiwo ƒe kaka eye wòhea dɔgboa ƒe tsi ƒuƒlu ɖe megbe. Esia ɖea nuɖuɖu ƒe dzodzro kple nuɖuɖumeŋusẽ dzi kpɔtɔna ŋutɔ, si wɔnɛ be ame ƒe lolo dzi ɖena kpɔtɔna atraɖii, eye wòwɔa dɔ nyuie le ƒodo me ami dzi ɖeɖe kpɔtɔ me.
Ami ƒe catabolism dodo ɖe ŋgɔ
Peptide aɖewo (le kpɔɖeŋu me, AOD 9604) naa lipase ƒe dɔwɔwɔ wɔa dɔ le adipocytes me, si wɔnɛ be triglyceride hydrolysis kabakaba eye wòdoa fatty acid oxidation ɖe ŋgɔ hena ŋusẽ. Woxea mɔ na ami ƒe wɔwɔme hã, si wɔnɛ be ami ƒe ƒoƒo ɖe ŋutilã me dzi kpɔtɔna. Ne wotsɔ nusiwo dona tso agbenɔnɔ me kpe ɖe eŋu la, ŋusẽkpɔɖeamedzi siawo ganaa kpekpeme dzi ɖuɖu nyona ɖe edzi.
Lãmetsiŋusẽ siwo do ƒome kple kpekpeme dzi kpɔkpɔ
To leptin ƒe dɔlélenutsiŋutete ƒe nyonyome kple tsitsi ƒe lãmetsiŋusẽ ƒe dodo ɖe ŋgɔ me la, atike siwo wotu ɖe peptide dzi dzia basal metabolic rate ɖe edzi, wodoa ŋusẽzazã ɖe ŋgɔ, eye woɖea dɔléle siwo do ƒome kple lolo akpa ƒe afɔkua dzi kpɔtɔna (le kpɔɖeŋu me, ʋusɔgbɔdɔ, ʋumemi ƒe agbɔsɔsɔ fũ).
3. Tsitsi ƒe Lãmetsiŋusẽ ƒe Ðoɖowɔwɔ: Agbenɔƒe ƒe Kpekpeɖeŋu na Tsitsi Kple Lãmetsiŋusẽ
Atike siwo wotu ɖe peptide dzi wɔa akpa vevi aɖe le ƒe vovovowo me to tsitsi ƒe lãmetsi (GH)–insulin-like growth factor-1 (IGF-1) axis ƒe ɖoɖowɔwɔ pɛpɛpɛ me.
Ðeviwo ƒe tsitsi kple tsitsi dodo ɖe ŋgɔ
Peptide siwo ɖea tsitsi ƒe lãmetsiwo ɖa (le kpɔɖeŋu me, semorelin) koŋ doa ŋusẽ pituitary GH ƒe dodo, si doa ƒumeŋuɖui ƒe tsitsi kple lãmekawo ƒe tsitsi ɖe ŋgɔ ŋutɔ le ɖevi siwo ƒe tsitsime lãmetsiŋusẽ mele o me eye wònaa tsitsi ƒe megbetsitsi bliboa nyona ɖe edzi.
Nudede ame tsitsiwo ƒe lãmenugbagbeviwo ƒe tsitsi me
Le ƒe titinatɔwo kple ame tsitsi siwo ŋu GH ƒe ɖiɖi hena lãmekawo ƒe vuvu kple ami ƒe ƒuƒoƒo gome la, peptidewo abe tesamorelin ene doa GH ƒe dodo ɖe ŋgɔ, si naa ŋutilã si me ami mele o ƒe lolome dzina ɖe edzi, eɖea ami si le ƒodo me dzi kpɔtɔna, enaa ami ƒe nɔnɔme nyona ɖe edzi, eye wòhea lãmenugbagbeviwo ƒe tsitsi ɖe megbe.
Amewo ƒe agbɔsɔsɔ ƒe dɔ tɔxɛwo
Le dɔnɔ siwo ŋu HIV-dɔlékui ƒe lipodystrophy le gome la, peptide siwo kpɔa tsitsi ƒe lãmetsiwo dzi ɖea ami ƒe ƒuƒoƒo si mesɔ o dzi kpɔtɔna tiaa, wonaa ŋutilã ƒe wɔwɔme gada asɔ, eye wònaa lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe kuxi siwo atikewo hena vɛ la nyona ɖe edzi.
4. Ŋusẽ ƒe Tɔtrɔ ƒe Ŋgɔyiyi: Mɔ ƒe Dɔwɔna Nyuitɔ tso Lãmenugbagbeviwo dzi yi Dɔwɔɖoɖo ƒe Dzidzenuwo dzi
Atike siwo wotu ɖe peptide dzi doa ŋusẽ zazã nyuie ɖe ŋgɔ eye woɖɔa lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe kuxiwo ɖo to ŋusẽ ƒe asitɔtrɔ ƒe mɔnuwo dzi kpɔkpɔ le ŋutinu geɖe me.
Mitochondria ƒe dɔwɔwɔ dodo ɖe ŋgɔ
Peptide siwo woɖo ɖe mitochondria ŋu (le kpɔɖeŋu me, SS-31) kpɔa mitochondria ƒe lãkusi ƒe blibonyenye ta, doa adenosine triphosphate (ATP) ƒe wɔwɔ ɖe ŋgɔ, eye wodoa lãmenugbagbeviwo ƒe ŋusẽ ƒe dɔwɔwɔ nyuie ɖe ŋgɔ. Esia ɖea vi ŋutɔ le ŋutinu siwo hiã ŋusẽ geɖe abe dzi kple ƒunukpeƒeŋusẽ ene me, si wɔnɛ be ŋusẽ nana ame nyona ɖe edzi eye ɖeɖiteameŋu dzi ɖena kpɔtɔna.
Lãmetsiŋusẽ ƒe enzyme veviwo ƒe dɔwɔwɔ dzi kpɔkpɔ
Peptide aɖewo naa ŋusẽ-sesemɔwo abe AMPK ene wɔa dɔ, doa sukli si tsɔa nu 4 (GLUT4) ƒe ɖeɖefia ɖe ŋgɔ, doa sukli ƒe xɔxlɔ̃ ɖe lãmekawo kple ami ƒe lãkusiwo me ɖe ŋgɔ, eye wòxea mɔ na aklã me sukli ƒe dzɔdzɔ—si wɔnɛ be insulin ƒe seselelãme nyona ɖe edzi bliboe.
Lipid metabolism ƒe dɔlélewo dzi ɖeɖe kpɔtɔ
Peptide siwo woɖo taɖodzinu geɖe (le kpɔɖeŋu me, retatrutide) xea mɔ na ami ƒe vovototodedeameme, doa ami ƒe β-oxidation ɖe ŋgɔ, eye wòɖea triglyceride kple lipoprotein si ƒe kpekpeme le sue ŋutɔ (VLDL) ƒe agbɔsɔsɔ dzi kpɔtɔna. Le aklãdɔ si me ami mele o (NAFLD) dada me la, woɖea ŋutete fiana le ami ƒe gege ɖe aklã me dzi ɖeɖe kpɔtɔ me, si wɔnɛ be lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe dɔlélea nyona ɖe edzi bliboe.
Nyanuwuwuw
Lãmetsiŋusẽ kple lãmenugbagbeviwo ƒe dɔwɔwɔ nyuie wɔa akpa aɖe si womate ŋu aɖɔli o le amegbetɔ ƒe lãmesẽ me. Abe mɔ veviwo ene la, lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ, kpekpeme dzi ɖuɖu, tsitsi ƒe lãmetsiwo ƒe ɖoɖowɔwɔ, kple ŋusẽ ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ ƒe nyonyome do ƒome kplikplikpli kple ŋutilã ƒe dɔwɔwɔ nyuie kple mɔxexe ɖe dɔléle nu. Nu vevitɔ si le lãmenugbagbeviwo ƒe dɔwɔwɔ kple lãmenugbagbeviwo ƒe dɔwɔwɔ dzi kpɔkpɔ me le nuwo kple ŋusẽ ƒe asitɔtrɔ dzi kpɔkpɔ pɛpɛpɛ to lãmetsiŋusẽ ƒe kadodowo dzi, eye atike siwo wotu ɖe peptide dzi ƒe dzidziɖedzi na wokpɔ dɔwɔnu nyui siwo ŋu woɖo taɖodzinu ɖo be woatsɔ ade nu dɔ sia me. Tso suklidɔlélawo ƒe suklidɔlélawo ƒe suklidɔlélawo ƒe suklidɔ ƒe homeostasis dzi kpɔkpɔ dzi va ɖo ŋutilã ƒe wɔwɔme tɔtrɔ le ame siwo lolo akpa me dzi, kple tso kpekpeɖeŋu nana ɖeviwo ƒe tsitsi dzi va ɖo ame tsitsiwo ƒe lãmenugbagbeviwo ƒe tsitsi hehe ɖe megbe dzi la, atike siwo wotu ɖe peptide dzi ɖea asixɔxɔ si le wo zazã le agbenɔƒe vovovowo ŋu fiana. Woƒe viɖewo keke ta wu dzesi ɖeka ƒe nyonyome ko; wonana woate ŋu ade nu nya sesẽwo abe suklidɔ ƒe kuxiwo, dzitodzito ƒe afɔkuwo, kple ŋutinuwo ƒe dɔmawɔmawɔ nyuie ene me bliboe to mɔ vovovowo dzi kpɔkpɔ me.
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.
